NGL FINECHEM
Back to Cashflow Statement
|
NGL FINECHEM Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-1.08 Cr | ₹-1.08 Cr | ₹-1.08 Cr | ₹-1.30 Cr | - |
What is the latest Cash Flow from Financing Activities ratio of NGL FINECHEM ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2023 | ₹-1.08 Cr |
Mar2022 | ₹-1.08 Cr |
Mar2021 | ₹-1.08 Cr |
Mar2020 | ₹-1.30 Cr |
Mar2019 | - |
How is Cash Flow from Financing Activities of NGL FINECHEM Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2023 | ₹-1.08 Cr | Negative | |
Mar2022 | ₹-1.08 Cr | Negative | |
Mar2021 | ₹-1.08 Cr | Negative | |
Mar2020 | ₹-1.30 Cr | 0 | |
Mar2019 | - | - |
Compare Cash Flow from Financing Activities of peers of NGL FINECHEM
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NGL FINECHEM | ₹1,427.1 Cr | -9.7% | 7.5% | 64.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹363,535.0 Cr | 0.9% | -6.6% | 58.8% | Stock Analytics | |
CIPLA | ₹112,058.0 Cr | -1% | -5.6% | 54.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,414.0 Cr | 0.9% | 2.2% | 27.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹103,845.0 Cr | -2.2% | 6.2% | 21.2% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,676.3 Cr | 2.8% | -0.6% | 96.2% | Stock Analytics |
NGL FINECHEM Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NGL FINECHEM | -9.7% |
7.5% |
64.9% |
SENSEX | -1.6% |
-0.5% |
19.8% |
You may also like the below Video Courses